With RetaTracker, you can track hunger, cravings, protein, hydration, mood, energy, sleep, side effects, wins, notes, and weekly progress
Quick Answer: GLP-1 medications show clinically meaningful average weight loss in large-scale peer-reviewed trials - approximately 14.9% for semaglutide (STEP 1) and up to 20.9% for tirzepatide (SURMOUNT-1) under trial conditions
You are never locked into automatic billing
Please note: While some medications available through Gala GLP-1 are FDA-approved for weight management, compounded medications are not reviewed or approved by the FDA
10.1146/annurev.me.40.020189.002211